
 
 
 
 
 
 
 
 
  Claims 
 
 [I] A gene coding for a human cytotoxic T lymphocyte antigen 4-Immunoglobulin (hCTLA4-Ig) fusion protein comprising at least one plant-derived leader sequence selected from the group consisting of rice (Oryza sativa L.), tobacco ( Nicotiana tabacum), maize (Zea mays), soybean (Glycine max), wheat (Triticum aestivum), tomato (Lycopersicon esculentum), rape (Brassica napus) and potato ( Solanum tuberosum). 
 
 
 [2] The gene according to claim 1, wherein the plant-derived leader sequence is a RAmylA leader sequence. 
 
 
 [3] The gene according to claim 1, wherein, in the hCTLA4-Ig, Ig is hinge, CH ,and CH regions of CÎ³l of human IgGl. 
 
 
 [4] The gene according to claim 3, comprising the sequence shown in SEQ ID NO: 1. 
 
 
 [5] A recombinant vector pMYN409 comprising the hCTLA4-Ig fusion protein- coding gene as claimed in claim 4. 
 
 
 [6] A host cell transformed with the recombinant vector pMYN409 as claimed in claim 5. 
 
 
 [7] The host cell according to claim 6, wherein the host cell is selected from the group consisting of rice (Oryza sativa L.), tobacco (Nicotiana tabacum), maize ( Zea mays), soybean (Glycine max), wheat (Triticum aestivum), tomato ( Lycopersicon esculentum), rape (Brassica napus) and potato (Solanum tuberosum). 
 
 
 [8] The host cell according to claim 7, wherein the host cell is Oryza sativa L. (Accession No. KCTC 10618BP). 
 
 
 [9] A process for producing a recombinant hCTLA4-Ig fusion protein, comprising suspension culturing the host cell as claimed in claim 8. 
 
 
 [10] The process according to claim 9, wherein the suspension culturing employs a basal medium, such as Chu N6, AA or MS (Murashige and Skoog) medium, containing 10 to 60 g/L of sucrose as a carbon source, 0.1 to 2.0 mg/L of 2,4-D and 0.01 to 2.0 mg/L of kinetin as growth regulators, and hygromycin for selection. 
 
 
 [I I] An hCTLA4-Ig fusion protein produced by the process as claimed in claim 9.  
 
 
 [12] The gene according to claim 3, wherein Cys, Cys and Cys in the hinge are substituted with Ser, respectively. 
 
 
 [13] The gene according to claim 12, comprising the sequence shown in SEQ ID NO: 2. 
 
 
 [14] A recombinant vector pMYN413 comprising the hCTLA4-Ig fusion protein- coding gene as claimed in claim 13. 

 
 
 
 [15] A host cell transformed with the recombinant vector pMYN413 as claimed in claim 14. 
 
 
 [16] The host cell according to claim 15, wherein the host cell is selected from the group consisting of rice (Oryza sativa L.), tobacco (Nicotiana tabacum), maize ( Zea mays), soybean (Glycine max), wheat (Triticum aestivum), tomato ( Lycopersicon esculentum), rape (Brassica napus) and potato (Solanum tuberosum). 
 
 
 [17] The host cell according to claim 16, wherein the host cell is Oryza sativa L. (Accession No. KCTC 10767BP). 
 
 
 [18] A process for producing a recombinant hCTLA4-Ig fusion protein, comprising suspension culturing the host cell as claimed in claim 17. 
 
 
 [19] The process according to claim 18, wherein the suspension culturing employs a basal medium, such as Chu N6, AA or MS (Murashige and Skoog) medium, containing 10 to 60 g/L of sucrose as a carbon source, 0.1 to 2.0 mg/L of 2,4-D and 0.01 to 2.0 mg/L of kinetin as growth regulators, and hygromycin for selection. 
 
 
 [20] An hCTLA4-Ig fusion protein produced by the process as claimed in claim 18. 272 
 
 
 [21] The gene according to claim 3, wherein Pro in the CH domain is substituted with Ser. 
 
 
 [22] The gene according to claim 21, comprising the sequence shown in SEQ ID NO: 3. 
 
 
 [23] A recombinant vector pMYN414 comprising the hCTLA4-Ig fusion protein- coding gene as claimed in claim 22. 
 
 
 [24] A host cell transformed with the recombinant vector pMYN414 as claimed in claim 23. 
 
 
 [25] The host cell according to claim 24, wherein the host cell is selected from the group consisting of rice (Oryza sativa L.), tobacco (Nicotiana tabacum), maize ( Zea mays), soybean (Glycine max), wheat (Triticum aestivum), tomato ( Lycopersicon esculentum), rape (Brassica napus) and potato (Solanum tuberosum). 
 
 
 [26] The host cell according to claim 25, wherein the host cell is Oryza sativa L. (Accession No. KCTC 10768BP). 
 
 
 [27] A process for producing a recombinant hCTLA4-Ig fusion protein, comprising suspension culturing the host cell as claimed in claim 26. 
 
 
 [28] The process according to claim 27, wherein the suspension culturing employs a basal medium, such as Chu N6, AA or MS (Murashige and Skoog) medium, containing 10 to 60 g/L of sucrose as a carbon source, 0.1 to 2.0 mg/L of 2,4-D and 0.01 to 2.0 mg/L of kinetin as growth regulators, and hygromycin for selection. 
 
 
 [29] An hCTLA4-Ig fusion protein produced by the process as claimed in claim 27. 
 
 
 
 
 
 
 
 
 
 
 
